APA

Martínez-Borra J., López-Larrea C., González S., Fuentes D., Dieguez A., Deschamps E. M., Pérez-Pariente J. M., López-Vázquez A., de Francisco R. & Rodrigo L. (20021018). High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. : The American journal of gastroenterology.

Chicago

Martínez-Borra Jesús, López-Larrea Carlos, González Segundo, Fuentes Dolores, Dieguez Angeles, Deschamps Eva M, Pérez-Pariente J M, López-Vázquez Antonio, de Francisco Ruth and Rodrigo Luís. 20021018. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. : The American journal of gastroenterology.

Harvard

Martínez-Borra J., López-Larrea C., González S., Fuentes D., Dieguez A., Deschamps E. M., Pérez-Pariente J. M., López-Vázquez A., de Francisco R. and Rodrigo L. (20021018). High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. : The American journal of gastroenterology.

MLA

Martínez-Borra Jesús, López-Larrea Carlos, González Segundo, Fuentes Dolores, Dieguez Angeles, Deschamps Eva M, Pérez-Pariente J M, López-Vázquez Antonio, de Francisco Ruth and Rodrigo Luís. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. : The American journal of gastroenterology. 20021018.